Company
Evommune
| Industry | clinical-stage biotechnology company focused on immune-mediated inflammatory diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Evommune | Series C Funding | 2024-10-31 |
| Evommune | Series B Financing | 2023-06-28 |
| Evommune | Series B Funding | 2023-04-26 |